The 2025 edition of BioFutures features stories from across Indiana’s life sciences landscape, including emerging technologies, talent initiatives, and insights from some of the state’s most influential companies and institutions.
Indiana marked a major milestone in 2024, becoming the nation’s #1 state for life sciences exports. This achievement, driven by growth in areas like incretin therapies and nuclear medicine, generated more than $99 billion in economic activity. BioCrossroads supported this progress by aligning efforts across the sector and helping to create the conditions for continued innovation and investment.
Transforming Healthcare: Indiana’s Role in Revolutionizing Diabetes and Obesity Management
The 2024 BioCrossroads Life Sciences Summit, “Transforming Healthcare: Indiana’s Role in Revolutionizing Diabetes and Obesity Management,” brought together leaders from across Indiana and beyond, highlighting the groundbreaking advancements that are transforming how we address these conditions.